Latest news
CLRB Stock Surged 27% Today – Here’s Why Retail Is Bullish About Cellectar’s Blood Cancer Trial Data - StocktwitsStocktwits · Sat, 08 Aug 2026 09:53:06 GMTCLRB Q2'26 Earnings: revenue estimate is 0 USD - TradingViewTradingView · Thu, 06 Aug 2026 11:00:24 GMTEmpery Asset Management (CLRB) discloses 9.99% beneficial stake via stock and warrants - Stock TitanStock Titan · Tue, 04 Aug 2026 14:06:32 GMTCellectar Biosciences, Inc. Revenue Breakdown – NASDAQ:CLRB - TradingViewTradingView · Sat, 01 Aug 2026 04:57:16 GMTCLRB|Cellectar Biosciences Inc|Price:2.595|Chg%:+0.025 - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTCLRB Q1 2026 Earnings: Narrower-Than-Expected Loss Beats Estimates by 32% - Earnings Quality Analysis - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 04:40:33 GMTCellectar Biosciences to Report Second Quarter 2026 Financial Results and Provide Corporate Update on August 13 - quiverquant.comquiverquant.com · Thu, 30 Jul 2026 12:15:00 GMTCellectar Biosciences to Report Second Quarter Financial - GlobeNewswireGlobeNewswire · Thu, 30 Jul 2026 12:05:00 GMT